Development Events. In consideration for the rights granted to Provention under this Agreement, Provention shall make the following one-time, non-refundable, non-creditable (i.e., to any other obligation of Provention hereunder) Development Event Payments (each, a “Development Event Payment”) to MacroGenics, upon the first achievement by a member of the Provention Group of the corresponding event (each, a “Development Event”). Each Development Event Payment listed in the table below shall be payable only once upon the first achievement of the corresponding Development Event.
Development Events. All events that are considered to be for the purpose of cultivating, stewarding, and/or recognizing donors and prospective donors of LCCC shall be cleared through the Foundation to ensure coordination of fundraising activities. The Foundation is not responsible for directing or coordinating events for LCCC that are not for the purposes outlined in this section.
Development Events. In connection with the Discovery and Development of Licensed Products that are Covered by a Valid Claim of Licensed Patent Rights, or the Manufacture of which Licensed Products is Covered by a Valid Claim of a Licensed Patent Right, and directed against a given Target hereunder, Licensee shall pay, or cause to be paid, to Alnylam the following payments upon the achievement of the events set forth below: Payment for Licensed Products Development Event: (in [**]): Initiation of GLP Toxicology Studies $ [**] Initiation of the first Phase I Study $ [**] Initiation of the first Phase II Study $ [**] Initiation of the first Phase III Study for the first Indication $ [**] Initiation of first Phase III Study for a second Indication $ [**] First filing of an NDA in the U.S. for the first Indication $ [**] First filing of an NDA in the EU for the first Indication $ [**] First filing of an NDA in Japan for the first Indication $ [**] First filing of an NDA in the U.S. or EU for a second Indication $ [**] Regulatory Approval in the U.S. for the first Indication $ [**] Regulatory Approval in the EU for the first Indication $ [**] Regulatory Approval in Japan for the first Indication $ [**] Regulatory Approval in the U.S. or EU for a second Indication $ [**]
Development Events. (i) Until such time as either Party exercises its Opt-Out Right, Roche shall pay Alnylam [**] percent ([**]%) of the payments set forth in Column A below upon achievement of the corresponding event set forth below by or on behalf of Roche or any of its Related Parties.
Development Events. Within thirty (30) days of the date of achievement of the applicable Development Event described below, Roche will pay to SGX the following non-refundable event payments on a Collaboration Product-by-Collaboration Product basis:
Development Events. (a) For each Development Target, MAGENTA shall pay up to a total of [***] upon achievement of the following development events by a Product directed toward such Development Target (each, a “Development Milestone”): (In Million USD) Development Event 1st Indication 2nd Indication [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***]
Development Events. For the purposes of this Agreement, the rate of [*] as determined by step 3 [*] will be used for certain development payments and project decisions.
Development Events. All events that are considered to be for the purpose of cultivating, stewarding, and/or recognizing donors and prospective donors shall be cleared through the Foundation to ensure coordination of fundraising activities. The Foundation is not responsible for directing or coordinating events for the Consortium Board that are not for the purposes outlined in this section.
Development Events. In consideration for the rights granted to Provention under this Agreement, Provention shall make the following one-time, non-refundable, non-creditable (i.e., to any other obligation of Provention hereunder) Development Event Payments (each, a “Development Event Payment”) to MacroGenics, upon the first achievement by a member of the Provention Group of the corresponding event (each, a “Development Event”). Each Development Event Payment listed in the table below shall be payable only once upon the first achievement of the corresponding Development Event. Development Event Payment Development Event For 1st Indication For 2nd Indication [****] [****]United States dollars ($[****]) [****] [****] [****] United States dollars ($[****]) [****] United States dollars ($[****]) [****] [****] United States dollars ($[****]) [****] United States dollars ($[****]) [****] [****] United States dollars ($[****]) [****] United States dollars ($[****]) If for any reason the Phase III Study Development Event for any Indication does not occur prior to the occurrence of any BLA Approval Development Event for such Indication, then the Phase III Study Development Event shall be deemed to occur concurrently with the occurrence of the first BLA Approval Development Event.
Development Events. All events that are considered to be for the purpose of cultivating, stewarding, and/or recognizing donors and prospective donors of the University shall be cleared through the Foundation to ensure coordination of fundraising activities.
